Company Filing History:
Years Active: 2006-2007
Title: Mark C Walker: Innovator in Biochemical Engineering
Introduction
Mark C Walker is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biochemical engineering, particularly in the development of novel enzymes and their applications.
Latest Patents
Mark C Walker holds 2 patents. His latest inventions include a novel cytochrome P450-like enzyme (11 alpha hydroxylase) and an oxidoreductase isolated from a cDNA library generated from the mRNA of spores. These enzymes have been shown to catalyze the conversion of the steroid substrate 4-androstene-3,17-dione (AD) to 11 alpha-hydroxy-AD. The invention also encompasses nucleic acid molecules associated with these cDNAs, methods for generating polypeptides, and the development of antibodies that recognize the 11 alpha hydroxylase and oxidoreductase.
Career Highlights
Mark C Walker is affiliated with Pharmacia Corporation, where he has been instrumental in advancing research in enzymatic processes. His work has paved the way for innovative methods of expressing the 11 alpha hydroxylase gene in heterologous host cells, facilitating the bioconversion of steroid substrates.
Collaborations
Some of his notable coworkers include Suzanne L Bolten and Robert Clayton. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Mark C Walker's innovative work in the field of biochemical engineering has led to significant advancements in enzyme technology and its applications. His contributions continue to impact the industry positively.